Maravai Lifesciences Holdings Stock Beta

MRVI Stock  USD 2.97  1.04  25.94%   
Maravai Lifesciences Holdings fundamentals help investors to digest information that contributes to Maravai Lifesciences' financial success or failures. It also enables traders to predict the movement of Maravai Stock. The fundamental analysis module provides a way to measure Maravai Lifesciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Maravai Lifesciences stock.
Short Long Term Debt TotalTotal Assets
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Maravai Lifesciences Holdings Company Beta Analysis

Maravai Lifesciences' Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.

Beta

 = 

Covariance

Variance

More About Beta | All Equity Analysis

Current Maravai Lifesciences Beta

    
  -0.08  
Most of Maravai Lifesciences' fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Maravai Lifesciences Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Maravai Beta Driver Correlations

Understanding the fundamental principles of building solid financial models for Maravai Lifesciences is extremely important. It helps to project a fair market value of Maravai Stock properly, considering its historical fundamentals such as Beta. Since Maravai Lifesciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Maravai Lifesciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Maravai Lifesciences' interrelated accounts and indicators.
0.870.880.21-0.920.920.660.930.960.420.940.950.930.98-0.940.970.91-0.29-0.940.72-0.87-0.35-0.35
0.870.82-0.19-0.930.950.780.780.810.680.650.960.730.92-0.750.940.820.11-0.750.73-0.95-0.36-0.36
0.880.82-0.08-0.950.850.770.80.850.280.790.860.80.91-0.820.920.78-0.4-0.820.49-0.85-0.41-0.41
0.21-0.19-0.080.13-0.05-0.160.390.15-0.110.430.050.460.13-0.410.070.34-0.39-0.410.280.110.080.08
-0.92-0.93-0.950.13-0.96-0.75-0.82-0.88-0.47-0.77-0.94-0.8-0.950.84-0.96-0.820.160.84-0.590.950.460.46
0.920.950.85-0.05-0.960.750.860.850.640.750.960.820.94-0.870.940.880.02-0.870.76-0.98-0.57-0.57
0.660.780.77-0.16-0.750.750.730.510.670.430.80.680.78-0.670.80.760.03-0.670.74-0.84-0.43-0.43
0.930.780.80.39-0.820.860.730.80.550.850.920.990.94-0.980.920.99-0.2-0.980.81-0.86-0.47-0.47
0.960.810.850.15-0.880.850.510.80.220.950.860.810.9-0.840.890.78-0.4-0.840.56-0.77-0.26-0.26
0.420.680.28-0.11-0.470.640.670.550.220.120.660.450.54-0.460.550.640.68-0.460.78-0.71-0.43-0.43
0.940.650.790.43-0.770.750.430.850.950.120.780.890.85-0.90.830.8-0.54-0.90.57-0.67-0.28-0.28
0.950.960.860.05-0.940.960.80.920.860.660.780.890.99-0.90.990.95-0.02-0.90.8-0.96-0.43-0.43
0.930.730.80.46-0.80.820.680.990.810.450.890.890.93-0.990.910.97-0.31-0.990.76-0.81-0.41-0.41
0.980.920.910.13-0.950.940.780.940.90.540.850.990.93-0.931.00.95-0.19-0.930.76-0.93-0.37-0.37
-0.94-0.75-0.82-0.410.84-0.87-0.67-0.98-0.84-0.46-0.9-0.9-0.99-0.93-0.91-0.970.291.0-0.770.840.460.46
0.970.940.920.07-0.960.940.80.920.890.550.830.990.911.0-0.910.93-0.17-0.910.74-0.94-0.37-0.37
0.910.820.780.34-0.820.880.760.990.780.640.80.950.970.95-0.970.93-0.1-0.970.85-0.88-0.41-0.41
-0.290.11-0.4-0.390.160.020.03-0.2-0.40.68-0.54-0.02-0.31-0.190.29-0.17-0.10.290.17-0.08-0.19-0.19
-0.94-0.75-0.82-0.410.84-0.87-0.67-0.98-0.84-0.46-0.9-0.9-0.99-0.931.0-0.91-0.970.29-0.770.840.460.46
0.720.730.490.28-0.590.760.740.810.560.780.570.80.760.76-0.770.740.850.17-0.77-0.77-0.39-0.39
-0.87-0.95-0.850.110.95-0.98-0.84-0.86-0.77-0.71-0.67-0.96-0.81-0.930.84-0.94-0.88-0.080.84-0.770.590.59
-0.35-0.36-0.410.080.46-0.57-0.43-0.47-0.26-0.43-0.28-0.43-0.41-0.370.46-0.37-0.41-0.190.46-0.390.591.0
-0.35-0.36-0.410.080.46-0.57-0.43-0.47-0.26-0.43-0.28-0.43-0.41-0.370.46-0.37-0.41-0.190.46-0.390.591.0
Click cells to compare fundamentals
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
Competition

In accordance with the recently published financial statements, Maravai Lifesciences Holdings has a Beta of -0.08. This is 109.3% lower than that of the Life Sciences Tools & Services sector and 105.76% lower than that of the Health Care industry. The beta for all United States stocks is 46.67% lower than that of the firm.

Maravai Beta Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Maravai Lifesciences' direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Maravai Lifesciences could also be used in its relative valuation, which is a method of valuing Maravai Lifesciences by comparing valuation metrics of similar companies.
100%
Maravai Lifesciences is currently under evaluation in beta category among its peers.

Maravai Lifesciences ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Maravai Lifesciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Maravai Lifesciences' managers, analysts, and investors.
58.6%
Environmental
75.6%
Governance
Social

Maravai Lifesciences Institutional Holders

Institutional Holdings refers to the ownership stake in Maravai Lifesciences that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Maravai Lifesciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Maravai Lifesciences' value.
Shares
Jennison Associates Llc2024-12-31
M
Geode Capital Management, Llc2024-12-31
2.8 M
State Street Corp2024-12-31
2.8 M
Marshall Wace Asset Management Ltd2024-12-31
2.8 M
Point72 (difc) Ltd2024-09-30
2.7 M
Glenmede Trust Co Na2024-12-31
2.2 M
Morgan Stanley - Brokerage Accounts2024-12-31
2.2 M
Bamco Inc2024-12-31
2.2 M
Fmr Inc2024-12-31
2.1 M
Gtcr Llc2024-12-31
20.2 M
Vanguard Group Inc2024-12-31
11.8 M
As returns on the market increase, returns on owning Maravai Lifesciences are expected to decrease at a much lower rate. During the bear market, Maravai Lifesciences is likely to outperform the market.

Maravai Fundamentals

Return On Equity-0.43
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-1,000%-500%0%
Return On Asset-0.0161
Profit Margin(0.81) %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-500%-400%-300%-200%-100%0%100%
Operating Margin(0.23) %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-100%0%100%200%300%400%
Current Valuation551.71 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-30%-20%-10%0%10%
Shares Outstanding141.84 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3150%100%150%
Shares Owned By Insiders1.00 %
Shares Owned By Institutions99.70 %
Number Of Shares Shorted8.54 M
Price To Earning7.79 X
Price To Book1.68 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-50%0%50%
Price To Sales3.66 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-80%-60%-40%-20%
Revenue288.94 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31100%200%300%400%500%600%
Gross Profit128.38 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31200%400%600%800%1,000%
EBITDA712.41 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31500%1,000%1,500%2,000%
Net Income(119.03 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-2,500%-2,000%-1,500%-1,000%-500%0%500%
Cash And Equivalents617.45 M
Cash Per Share4.69 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31500%1,000%1,500%
Total Debt610.97 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3120%40%60%80%100%
Debt To Equity0.69 %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-50%0%50%100%150%
Current Ratio7.22 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31100%200%300%400%
Book Value Per Share2.44 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%50%100%150%200%250%300%
Cash Flow From Operations126.22 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-250,000%-200,000%-150,000%-100,000%-50,000%
Short Ratio4.14 X
Earnings Per Share(1.67) X
Price To Earnings To Growth(0.22) X
Target Price9.33
Number Of Employees580
Beta-0.08
Market Capitalization1.01 B
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-30%-20%-10%0%
Total Asset1.49 B
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3150%100%150%200%250%300%
Retained Earnings285.74 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-1,200%-1,000%-800%-600%-400%-200%0%
Working Capital612.44 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Net Asset1.49 B

About Maravai Lifesciences Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Maravai Lifesciences Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Maravai Lifesciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Maravai Lifesciences Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

When determining whether Maravai Lifesciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Maravai Lifesciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Maravai Lifesciences Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Maravai Lifesciences Holdings Stock:
Check out Maravai Lifesciences Piotroski F Score and Maravai Lifesciences Altman Z Score analysis.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Maravai Lifesciences. If investors know Maravai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Maravai Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.33)
Earnings Share
(1.67)
Revenue Per Share
2.044
Quarterly Revenue Growth
(0.03)
Return On Assets
(0.02)
The market value of Maravai Lifesciences is measured differently than its book value, which is the value of Maravai that is recorded on the company's balance sheet. Investors also form their own opinion of Maravai Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Maravai Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Maravai Lifesciences' market value can be influenced by many factors that don't directly affect Maravai Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Maravai Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Maravai Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Maravai Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.